Mark Roschewski
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment 90
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research 41
- Oncology top 2%
- CAR-T cell therapy research 32
- Viral-associated cancers and disorders 14
- Hematology top 2%
- Multiple Myeloma Research and Treatments 17
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 25
-
- CNS Lymphoma Diagnosis and Treatment 25
-
- Lung Cancer Treatments and Mutations 12
- Co-authors
- Wyndham H. WilsonLouis M. StaudtKieron DunleavyStefania PittalugaElaine S. JaffeSeth M. SteinbergChristopher MelaniMargaret Shovlin
- Partner nations
- United StatesUnited KingdomSwitzerland
In The Last Decade
Mark Roschewski
121 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 101
- Pathology and Forensic Medicine 1.4k
- Genetics 627
- Oncology 1.3k
- Hematology 485
- Cancer Research 549
Countries citing papers authored by Mark Roschewski
This map shows the geographic impact of Mark Roschewski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Roschewski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Roschewski more than expected).
Fields of papers citing papers by Mark Roschewski
This network shows the impact of papers produced by Mark Roschewski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Roschewski. The network helps show where Mark Roschewski may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark Roschewski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 13 | |
| 5 | 2024 | 6 | |
| 6 | 2024 | 0 | |
| 7 | 2023 | 5 | |
| 8 | 2023 | 13 | |
| 9 | 2022 | 55 | |
| 10 | 2021 | 8 | |
| 11 | Systemic Approach to Recurrent Primary CNS Lymphoma: Perspective on Current and Emerging Treatment Strategies | 2020 | 1 |
| 12 | 2020 | 26 | |
| 13 | 2019 | 0 | |
| 14 | 2018 | 3 | |
| 15 | 2016 | 111 | |
| 16 | 2012 | 61 | |
| 17 | 2012 | 72 | |
| 18 | 2012 | 56 | |
| 19 | 2011 | 29 | |
| 20 | 2010 | 11 |
About Mark Roschewski
Mark Roschewski is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology, having authored 131 papers that have together received 2.9k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (90 papers), Chronic Lymphocytic Leukemia Research (41 papers), CAR-T cell therapy research (32 papers), CNS Lymphoma Diagnosis and Treatment (25 papers), Cancer Genomics and Diagnostics (25 papers), Multiple Myeloma Research and Treatments (17 papers), Viral-associated cancers and disorders (14 papers) and Lung Cancer Treatments and Mutations (12 papers). The work is most often cited by research in Pathology and Forensic Medicine (1.4k citations), Genetics (627 citations) and Oncology (1.3k citations). Mark Roschewski has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Wyndham H. Wilson, Louis M. Staudt, Kieron Dunleavy, Stefania Pittaluga, Elaine S. Jaffe, Seth M. Steinberg, Christopher Melani, Margaret Shovlin, Ola Landgren and Neha Korde. Their work appears in journals such as Blood, Journal of Clinical Oncology, Blood Advances, Hematological Oncology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.